From: Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Group | 2008 | 2015 |
---|---|---|
Population | 5.8 (4.9, 6.8) | 6.8 (5.8, 7.9) |
 Female | 3.4 (2.6, 4.5) | 2.4 (1.8, 3.2) |
 Male | 8.3 (6.8, 10.1) | 11.3 (9.6, 13.4) |
 25–34 years | 1.3 (0.5, 3.1) | 0.8 (0.3, 2.6) |
 35–44 years | 2.3 (1.2, 4.3) | 2.9 (1.4, 5.8) |
 45–54 years | 3.1 (1.9, 5.0) | 6.9 (4.7, 10.0) |
 55–64 years | 8.3 (5.8, 11.6) | 7.4 (5.2, 10.3) |
 65+ years | 13.4 (10.9, 16.4) | 13.9 (12.0, 16.2) |